FR2848448B1 - Utilisation d'un extrait de grains de cafe decafeine dans la preparation d'une composition destinee a stimuler la fonction sebacee de la peau par administration orale - Google Patents

Utilisation d'un extrait de grains de cafe decafeine dans la preparation d'une composition destinee a stimuler la fonction sebacee de la peau par administration orale

Info

Publication number
FR2848448B1
FR2848448B1 FR0215867A FR0215867A FR2848448B1 FR 2848448 B1 FR2848448 B1 FR 2848448B1 FR 0215867 A FR0215867 A FR 0215867A FR 0215867 A FR0215867 A FR 0215867A FR 2848448 B1 FR2848448 B1 FR 2848448B1
Authority
FR
France
Prior art keywords
decaffein
stimulating
skin
preparation
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR0215867A
Other languages
English (en)
Other versions
FR2848448A1 (fr
Inventor
Lionel Breton
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
LOreal SA
Original Assignee
LOreal SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=32338797&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=FR2848448(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by LOreal SA filed Critical LOreal SA
Priority to FR0215867A priority Critical patent/FR2848448B1/fr
Priority to EP03782492A priority patent/EP1572145A1/fr
Priority to AU2003290130A priority patent/AU2003290130B2/en
Priority to MXPA05006269A priority patent/MXPA05006269A/es
Priority to PCT/EP2003/015026 priority patent/WO2004054535A1/fr
Priority to CA002508712A priority patent/CA2508712A1/fr
Priority to BR0317239-2A priority patent/BR0317239A/pt
Priority to JP2005502448A priority patent/JP2006511603A/ja
Priority to CNA2003801059661A priority patent/CN1726007A/zh
Priority to KR1020057010351A priority patent/KR20050094403A/ko
Publication of FR2848448A1 publication Critical patent/FR2848448A1/fr
Priority to US11/150,163 priority patent/US20060018986A1/en
Publication of FR2848448B1 publication Critical patent/FR2848448B1/fr
Application granted granted Critical
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/74—Rubiaceae (Madder family)
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783—Angiosperms [Magnoliophyta]
    • A61K8/9789—Magnoliopsida [dicotyledons]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/007—Preparations for dry skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
    • A61K2800/92—Oral administration
FR0215867A 2002-12-13 2002-12-13 Utilisation d'un extrait de grains de cafe decafeine dans la preparation d'une composition destinee a stimuler la fonction sebacee de la peau par administration orale Expired - Fee Related FR2848448B1 (fr)

Priority Applications (11)

Application Number Priority Date Filing Date Title
FR0215867A FR2848448B1 (fr) 2002-12-13 2002-12-13 Utilisation d'un extrait de grains de cafe decafeine dans la preparation d'une composition destinee a stimuler la fonction sebacee de la peau par administration orale
BR0317239-2A BR0317239A (pt) 2002-12-13 2003-12-12 Composição pretendida para estimular a função sebácea da pele, procedimento cosmético para o tratamento e/ou a prevenção de peles secas ou para o tratamento e/ou a prevenção do envelhecimento da pele, e, uso de um extrato de grão de café descafeinado na preparação de uma composição pretendida
CNA2003801059661A CN1726007A (zh) 2002-12-13 2003-12-12 除去咖啡因的咖啡豆提取物在制备通过口服给药用于刺激皮肤皮脂功能的组合物中的用途
MXPA05006269A MXPA05006269A (es) 2002-12-13 2003-12-12 Uso de un extracto de granos de cafe descafeinado en la preparacion de una composicion destinada a estimular la funcion sebacea de la piel mediante administracion oral.
PCT/EP2003/015026 WO2004054535A1 (fr) 2002-12-13 2003-12-12 Utilisation d'un extrait de grains de cafe decafeines dans la preparation d'une composition servant a stimuler la fonction sebacee de la peau administree par voie orale
CA002508712A CA2508712A1 (fr) 2002-12-13 2003-12-12 Utilisation d'un extrait de grains de cafe decafeines dans la preparation d'une composition servant a stimuler la fonction sebacee de la peau administree par voie orale
EP03782492A EP1572145A1 (fr) 2002-12-13 2003-12-12 Utilisation d'un extrait de grains de cafe decafeines dans la preparation d'une composition servant a stimuler la fonction sebacee de la peau administree par voie orale
JP2005502448A JP2006511603A (ja) 2002-12-13 2003-12-12 経口投与による皮膚の皮脂腺機能を刺激することを意図した組成物の調製における脱カフェインされたコーヒー豆抽出物の使用
AU2003290130A AU2003290130B2 (en) 2002-12-13 2003-12-12 Use of an extract of decaffeinated coffee beans in the preparation of a composition intended to stimulate the sebaceous function of the skin by oral administration
KR1020057010351A KR20050094403A (ko) 2002-12-13 2003-12-12 경구 투여로 피부의 피지 기능을 자극하기 위한 조성물제조에서의 카페인 제거 커피 원두 추출물의 용도
US11/150,163 US20060018986A1 (en) 2002-12-13 2005-06-13 Extracts of decaffeinated coffee beans and orally administrable compositions comprised thereof for stimulating the sebaceous function of the skin

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0215867A FR2848448B1 (fr) 2002-12-13 2002-12-13 Utilisation d'un extrait de grains de cafe decafeine dans la preparation d'une composition destinee a stimuler la fonction sebacee de la peau par administration orale

Publications (2)

Publication Number Publication Date
FR2848448A1 FR2848448A1 (fr) 2004-06-18
FR2848448B1 true FR2848448B1 (fr) 2007-04-06

Family

ID=32338797

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0215867A Expired - Fee Related FR2848448B1 (fr) 2002-12-13 2002-12-13 Utilisation d'un extrait de grains de cafe decafeine dans la preparation d'une composition destinee a stimuler la fonction sebacee de la peau par administration orale

Country Status (3)

Country Link
JP (1) JP2006511603A (fr)
CN (1) CN1726007A (fr)
FR (1) FR2848448B1 (fr)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2008503563A (ja) * 2004-06-23 2008-02-07 ロレアル 敏感及び／又は乾燥肌の予防及び／又は処置に有用な方法及び組成物
FR2872047B1 (fr) * 2004-06-23 2007-06-15 Oreal Composition pour peaux sensibles associant cation mineral et probiotique(s)
CN1879727B (zh) * 2006-05-09 2010-04-21 中国科学院上海药物研究所 新型抗乙肝病毒抑制剂及其应用
FR2920304B1 (fr) 2007-09-04 2010-06-25 Oreal Utilisation cosmetique de lysat bifidobacterium species pour le traitement de la secheresse.
FR2920305B1 (fr) 2007-09-04 2010-07-30 Oreal Utilisation d'un lysat de bifidobacterium species pour le traitement de peaux sensibles.
FR2942719B1 (fr) 2009-03-04 2011-08-19 Oreal Utilisation de microorganismes probiotiques pour limiter les irritations cutanees
WO2012013776A2 (fr) * 2010-07-30 2012-02-02 Nestec S.A. Utilisation de grains de café vert pour réguler des troubles de la pigmentation de la peau
CN103068360B (zh) * 2010-07-30 2015-11-25 雀巢产品技术援助有限公司 烘焙咖啡豆和生咖啡豆的混合物用于调节皮肤色素沉着的用途
BR112013002216B1 (pt) * 2010-07-30 2018-11-06 L'oreal uso cosmético de grãos de café torrado
CN103616426B (zh) 2013-12-02 2016-05-11 中国科学院上海应用物理研究所 一种用于快速生化分析的集成式的微流控电化学生物传感系统及其使用方法
FR3030253B1 (fr) * 2014-12-18 2018-03-02 Nutricos Technologies Composition pour ameliorer l'aspect cellulitique de la peau
CN111616995A (zh) * 2020-04-14 2020-09-04 云南英格生物技术有限公司 一种咖啡银皮提取物及其制备方法和应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1533371A (fr) * 1967-06-07 1968-07-19 Produits dermo-cosmétiques à base d'extraits de caféier
US3660107A (en) * 1970-01-23 1972-05-02 Meyer Lab Inc Effervescent beverage powder and tableted beverage compositions
DE3920209A1 (de) * 1989-06-21 1991-03-28 Nolde Sylvia Kaffee-pralinen (-riegel,-tafeln u.ae.m.), coffeinfrei
ES2071937T3 (es) * 1991-09-23 1995-07-01 Kraft Foods Inc Productos de cafe descafeinado con contenido en potasio reducido.
EP0582147A3 (en) * 1992-08-03 1994-08-24 Nestle Sa Anti-urease cosmetic or dermatologic composition
IT1290806B1 (it) * 1997-03-21 1998-12-11 Universal Flavors S R L Estratti decaffeinati di mate'
US20020160067A1 (en) * 2001-04-25 2002-10-31 Oncology Science Corporation Therapeutic preparation and method for producing a therapeutic preparation using coffee beans as a substrate

Also Published As

Publication number Publication date
FR2848448A1 (fr) 2004-06-18
JP2006511603A (ja) 2006-04-06
CN1726007A (zh) 2006-01-25

Similar Documents

Publication Publication Date Title
HK1089701A1 (en) Use of a cosmetic or pharmaceutical composition, comprising a lupeol-rich extract as an active ingredient for stimulating the synthesis of heat shock proteins
FR2848448B1 (fr) Utilisation d'un extrait de grains de cafe decafeine dans la preparation d'une composition destinee a stimuler la fonction sebacee de la peau par administration orale
IL171683A (en) Immunosuppressive Compounds, Medicinal Products Containing Them and Their Use in the Preparation of Medication for Treatment
HK1082916A1 (en) Composition for preparation for external use on skin
AU2003290130A8 (en) Use of an extract of decaffeinated coffee beans in the preparation of a composition intended to stimulate the sebaceous function of the skin by oral administration
TWI340640B (en) Combination, kit and pharmaceutical composition for treatment of parkinson's disease
AU2003265831A8 (en) Hyperspectral imaging of the human retina
EP1623985A3 (fr) Métabolites d'indole-3-carbinol en tant qu'agents chimiothérapeutiques et de chemopréventive
IL167250A (en) Chirale oxazole-arylpropionic acid derivatives, compositions comprising thereof and their use in the preparation of medicaments for the treatment of ppar alpha/ ppar gamma agonists-modulated diseases
EP1695699A4 (fr) Grains contenant un medicament et preparation solide contenant les grains
ME01663B (fr) DERIVES DE <i>N</i>-(1 H-INDOLYL)-I <i>H</i>-IND0LE-2-CARB0XAMIDES, LEUR PREPARATION ET LEUR APPLICATION EN THERAPEUTIQUE
ITMI20031570A1 (it) Composizione per uso dietetico, farmaceutico o cosmetico
IL164463A (en) Use of osteoprotegerin in the preparation of medicaments
IL172423A0 (en) Novel formulations for opioid -based treatments of pain comprising substituted 1,4-di-piperidin-4-yl-piperazine derivatives
MA45043A (fr) Composés pour stimuler la croissance des cheveux et/ou inhiber ou retarder la chute des cheveux chez l'homme, et compositions pour de telles utilisations
EA200401515A1 (ru) Новые фармацевтические композиции, содержащие флибансерин в полиморфной модификации а
HRP20041157A2 (en) Piperazinylacylpiperidine derivatives, their preparation and therapeutic use thereof
EP1637132A4 (fr) Preparation externe permettant de traiter les pieds d'un athlete
ITMI20031396A1 (it) Composizione per uso farmaceutico o dietetico o cosmetico dotata di attivita' antiossidante.
PT1525193E (pt) Derivados do acilaminotiazole e sua utilização como inibidores de beta amilóide
HUP0203303A3 (en) Compositions for administering taxanes orally to human patients
AU2003248153A1 (en) Honey-based skin care preparation
HK1074444A1 (en) Acyloxypyrrolidine derivatives, preparation and therapeutic use thereof
TWI320413B (en) 1,4-diazabicyclo [ 3.2.2 ] nonanecarboxamide derivatives, preparation thereof and therapeutic use thereof
IL165851A0 (en) The use of benziselenazolone compounds in the preparation of medicament against ischemic myocardial injury

Legal Events

Date Code Title Description
ST Notification of lapse

Effective date: 20090831